Skip to main content
Clinical Trials/NL-OMON53719
NL-OMON53719
Recruiting
Not Applicable

ArteriaL Fluorescence Angiography for Peripheral Arterial Disease (ALFAPAD) Study - ALFAPAD

Medisch Spectrum Twente0 sites15 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
peripheral arterial disease
Sponsor
Medisch Spectrum Twente
Enrollment
15
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Peripheral arterial disease patients with a Rutherford classification of 4, 5

Exclusion Criteria

  • Severely impaired renal function (eGFR \< 30 ml/min)
  • Known allergy or hypersensitivity for iodine
  • Hyperthyroidism

Outcomes

Primary Outcomes

Not specified

Similar Trials